Skip to main content
Livermore
Livermore
ZHEN

HSBC Holdings PLC

SEC CIK
0000873630
Latest filing
Aug 14, 2026

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by HSBC Holdings PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overviewAll 13F holders of RAREFull Q2 2026 holdings

Shares (Q2 2026)
45,174
Value
$1.53M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of RARE by HSBC Holdings PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202645,174$1.53M<0.1%−6,463−12.5%ReducedHolders
Q1 202651,637$1.08M<0.1%+21,958+74.0%AddedHolders
Q4 202529,679$662.7K<0.1%−47,206−61.4%ReducedHolders
Q3 202576,885$2.30M<0.1%−20,312−20.9%ReducedHolders
Q2 202597,197$3.55M<0.1%+45,665+88.6%AddedHolders
Q1 202551,532$1.86M<0.1%+4,016+8.5%AddedHolders
Q4 202447,516$1.97M<0.1%+31,416+195.1%AddedHolders
Q3 202416,100$889.6K<0.1%+16,100NewHolders
Q2 20240$00.0%−17,349−100.0%Sold outHolders
Q1 202417,349$809.9K<0.1%−2,114−10.9%ReducedHolders
Q4 202319,463$930.7K<0.1%−7,512−27.8%ReducedHolders
Q3 202326,975$958.5K<0.1%+2,662+10.9%AddedHolders
Q2 202324,313$1.13M<0.1%−2,699−10.0%ReducedHolders
Q1 202327,012$1.08M<0.1%−45,468−62.7%ReducedHolders
Q4 202272,480$3.28M<0.1%+61,631+568.1%AddedHolders
Q3 202210,849$457.0K<0.1%−2,884−21.0%ReducedHolders
Q2 202213,733$810.0K<0.1%−935−6.4%ReducedHolders
Q1 202214,668$1.07M<0.1%+8,231+127.9%AddedHolders
Q4 20216,437$547.0K<0.1%−397−5.8%ReducedHolders
Q3 20216,834$611.0K<0.1%−1,838−21.2%ReducedHolders
Q2 20218,672$833.0K<0.1%+4,463+106.0%AddedHolders
Q1 20214,209$480.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.